1)国立がん研究センターがん情報サービス.http://ganjoho.jp/reg_stat/statistics/stat/short_pred.html
2)日本医学会 : 医療における遺伝学的検査・診断に関するガイドライン2011.http://jams.med.or.jp/guideline/genetics-diagnosis.pdf
Genetic/familial high-risk assessment : breast and ovarian, version 2. 2016
4)日本乳癌学会(編) : 科学的根拠に基づく乳癌診療ガイドライン② 疫学・診断編2015年版.金原出版,2015
5)Srivastava A, et al : Risk of breast and ovarian cancer in women with strong family histories. Oncology 15 : 889─902, 2001
6)Euhus DM, et al : Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94 : 844─851, 2002
7)Evans DG, et al : A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41 : 474─480, 2004
8)Antoniou AC, et al : A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86 : 76─83, 2002
9)Allison W, et al : Performance of BRCA1/2 mutation prediction models in asian americans. J Clin Oncol 26 : 4752─4758, 2008
10)Son BH, et al : Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea : The Korean Hereditary Breast Cancer(KOHBRA) Study. Breast Cancer Res Treat 133 : 1143─1152, 2012
11)Lincoln SE, et al : A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn 17 : 533─544, 2015
12)Buys SS, et al : A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123 : 1721─1730, 2017